deepdna.aiVerified
Pharmacogenomics for AI agents: cited drug–gene, gene and rsID lookups plus a medication screen.
HealthcareData access / search
- Passed: Handshake
- Passed: Tools listed
- Passed: Updated recently
Median latency 1277 ms · Last checked
Explore
Evidence for your next connection.
Independent measurements of remote MCP servers. Every observation has a timestamp.
Read-only probesMCP server · Data access / search
Negative results intelligence for drug discovery — query measured failures via MCP.
1 failed · 8 not measured
Median of successful probes over 7 days
Share of countable probes over 30 days, including daily rollups. Auth challenges are excluded.
Tool definitions returned by this server
Independent monitoring
Responded
The server completed its last measured handshake. This is an observation, not a guarantee.
Last checked| Test area | Passed | Failed | Unmeasured |
|---|---|---|---|
ConnectionCan a client connect and discover tools? | 5 | 0 | 0 |
Reliability & speedDoes it respond consistently and quickly? | 0 | 0 | 4 |
Access & authenticationWhat is required to use this server? | 1 | 0 | 2 |
Tool qualityAre the tool definitions usable by an agent? | 4 | 0 | 0 |
Publisher identityCan the publisher be traced to its source? | 3 | 1 | 2 |
Unmeasured means there is not enough evidence to decide. How these checks work
Start using ai.nullary/nullary
Choose your client, copy the configuration, then enable the server in your client’s MCP settings.
Run this command in your terminal, then restart Claude Code.
Claude Code
claude mcp add --transport http ai-nullary-nullary https://mcp.nullary.ai/mcpCapabilities
A compound (structure, name, max clinical phase) + its full negative profile across modalities/sources.
DiscoveredPer-modality and per-source coverage stats (honest Phase-1 numbers).
DiscoveredFull provenance + detail for a single finding by id.
DiscoveredPer-target Layer-1 model card: training counts and held-out scaffold-split metrics (ROC-AUC, PR-AUC, Brier, calibration). Accepts a gene symbol (e.g. EGFR) or UniProt accession (e.g. P00533).
DiscoveredTarget 'graveyard' / exhaustion index: how many distinct compounds/agents have been tried against a target and failed, broken down by modality and outcome. Answers 'how picked-over is this target?'. Accepts a gene symbol (e.g. EGFR) or a UniProt accession (e.g. P00533).
DiscoveredSummary of the Layer-1 inactivity-scoring model registry: how many per-target models, split by family, and median scaffold-split ROC-AUC.
DiscoveredCoverage browse: the most heavily-pursued ('graveyard') targets, ranked by recorded negative findings. Optional family filter (kinase, gpcr, protease, nuclear_receptor, ion_channel, transporter, phosphatase, other).
DiscoveredADC failures attributed to linker chemistry.
DiscoveredSmall-molecule ADMET failures.
DiscoveredADMET failures across ALL modalities.
DiscoveredAncestry-specific CRISPR failures.
DiscoveredBispecific format/engineering failures.
DiscoveredAntibody developability failures.
DiscoveredDrug-drug interaction failures.
DiscoveredADCs that failed at any stage.
DiscoveredBispecifics that failed at any stage.
DiscoveredDiscontinued/terminated clinical antibodies.
DiscoveredNon-dependency / failed essentiality screens.
DiscoveredFailed/ineffective CRISPR guides.
DiscoveredASOs/siRNAs that failed engagement/developability.
DiscoveredFailed peptide therapeutics.
DiscoveredPROTACs that failed degradation/ternary/permeability.
DiscoveredFindings that failed to replicate.
DiscoveredSmall molecules that failed selectivity.
DiscoveredFailed/terminated vaccines (by pathogen/indication).
DiscoveredInactive small-molecule compound-target pairs.
DiscoveredALL failed approaches for an indication across every modality.
DiscoveredApproaches that failed for a mechanism (by target).
DiscoveredOligonucleotide delivery failures.
DiscoveredVaccine + antimicrobial + antibody failures for a pathogen.
DiscoveredPeptide stability/half-life failures.
DiscoveredPROTAC E3-ligase recruitment / ternary failures.
DiscoveredClinical/preclinical safety failures across modalities.
DiscoveredALL failed approaches against a target across every modality.
DiscoveredFailed vaccine immunogen designs.
DiscoveredRecent measurements
| Checked | Result | Response | Tools |
|---|---|---|---|
| Connected | 468 ms | 35 |